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Hyperbaric oxygen (HBO) therapy has been suggested a treatment option in order to reduce
the development of secondary insults succeeding traumatic brain injury. This case report
studied the course of a 23-year-old gentleman with a close range transhemispheric gunshot
wound.The biochemical parameters, using a multi-modal monitoring in the neuro-intensive
care unit, improved following HBO treatment.
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INTRODUCTION
A 23-year-old male, previously healthy, was admitted to the emer-
gency room following a cerebral gunshot wound, at close range,
from a hand gun. On admission, the patient presented with a
Glasgow Coma Score (GCS) of 14 (E4+M6+V4), obeyed com-
mands, had normal pupil responses and extremity movement, yet
was agitated and restless. Respiratory and circulatory parameters
were stable. The entrance was located just behind the right ear,
no exit wound was visible. Subsequently, the patient was sedated,
intubated, and a full body CT-scan was performed, revealing no
extracranial injuries. A CT-scan of the head revealed several bone
fragments in the right temporal lobe below the entrance of the
bullet (Figure 1A), which progressed through the brain with a
bihemispheric central and transventricular trajectory. Along the
route, intraparenchymal- and subarachnoid-hemorrhages were
present (Figure 1B). The patient underwent wound revision and
monitoring neurosurgery, receiving a Licox® brain tissue oxime-
try device (PBtO2; Integra LifeSciences, Plainsboro, NJ, USA),
an intracerebral microdialysis catheter (CMA70, Microdialysis
AB, Stockholm, Sweden), an intracranial pressure (ICP) device
(Codman® DePuy Synthes, Johnson & Johnson Medical, New
Brunswick, NJ, USA), and an extra-ventricular drain (Medtronic,
Minneapolis, MN, USA). The patient was transferred to the neuro-
intensive care unit for further treatment. During the following day,
the patient deteriorated with an increased ICP, increased intrac-
erebral lactate:pyruvate ratio (LPR), and increased serum levels
of the biomarker S100B (Figure 2). This prompted an increase
in administration of sedatives (propofol and midazolam), itera-
tive doses of hypertonic saline, and infusion of pentobarbiturates.
Despite this, the ICP remained elevated. The neurosurgeon on call
decided to perform a hemicraniectomy in order to improve the
intracranial conditions. Following the procedure, the ICP returned
to normal levels (<20 mmHg), although the LPR remained high
(>40) (Figure 2). The post-operative CT-scan revealed hypodense
areas, indicating edema or that the tissue was at risk for ischemia,
primarily in the cerebral areas supplied by the posterior circulation
(Figure 3).
On day 7 post-trauma, the patient deteriorated further, with
increasing LPR and S100B levels, yet normal cerebral oxygena-
tion (PBtO2 >15mm Hg), hence not indicating ischemia, though
perhaps an ongoing mitochondrial dysfunction with a metabolic
crisis. This lead to the initiation of hyperbaric oxygen (HBO) treat-
ment (75 min, 2.8 bar with two air-brakes, followed by a stage-wise
decompression during 40 min), which had an imminent, and sta-
bilizing, effect on the LPR (Figures 2 and 4). The ICP remained
normal (<20 mmHg) throughout the HBO treatment period. The
PBtO2 was not monitored during the HBO, because of technical
issues, but showed a sustained increase to levels above 20 mmHg
after the completed hyperbaric treatment, allowing the decrease
of fraction of inspired oxygen (FiO2) (Figure 5). The secondary
increase of S100B stopped, and was followed by a steady decline
(Figure 2). The focal LPR is measured using the microdialysis tech-
nique, which is compatible to use inside the hyperbaric chamber.
However, the measured levels may not be completely reliable dur-
ing the compression and decompression phases, since the speed
of perfusion is influenced by the surrounding pressure changes.
The patient received two further HBO treatments, same type and
duration, on day 8 and day 10 post-trauma. In order to visualize
the changes before and after HBO treatment, Figure 4 shows LPR,
PBtO2, and ICP during the 3 days of HBO treatment. The LPR
has the highest level after the HBO treatment, which is a single
sample, and thus presumably false. Following this peak, there is a
sustained period of lower LPR samples.
Day 16 after injury, the patient was provided with a tra-
cheostomy. A MRI on day 16 showed bilateral temporal damage
with cytotoxic edema along the trajectory, yet no ischemic injury
or permanent damage to the frontal lobes (Figure 6). Neurophys-
iological examination on day 27 revealed signs of bilateral cortical
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blindness (no visually evoked potentials detected), no signs of
brain stem damage (normal brainstem auditory evoked poten-
tials, BAEP), and no irregularities on the electromyogram (EMG).
The patient himself was not aware of being blind.
On day 36, the patient was discharged from NICU to an
intermediate neurosurgical ward.
The patient started physiotherapy and at day 38 after injury,
he was able to move with support. At discharge from the
FIGURE 1 |The admission CT-scan, (A) highlights the bone fragments
close to the entry point behind the right ear (ring). (B) Illustrates the bullet
(ring) and its trajectory (arrows).
neurosurgical clinic, the patient was still blind and had cognitive
deficits yet had regained almost all motoric functions and could
walk a shorter distance without support. Six months after trauma,
the patient is still dependent on medical staff in order to move, as
well as suffering from cortical blindness and cognitive shortfall.
FIGURE 3 | Post-operative CT (after hemicraniectomy) day 2. The white
arrows highlight the hypodense regions of brain parenchyma in the
posterior circulation which is tissue at risk for subsequent ischemic injury.
FIGURE 2 | Illustrating how the lactate:pyruvate ratio (LPR, black), the central perfusion pressure (CPP, blue), the intracranial pressure (ICP, green), and
S100B (red) levels changed over time. The first red arrow indicates the time for hemicraniectomy (“surgery”) while the other three highlight the timings for
HBO treatment.
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FIGURE 4 | Lactate:pyruvate ratio (LPR, black), intracranial pressure (ICP, blue), and the brain tissue oxygen pressure (PBtO2, red) changes during HBO
treatment (red blocks).
BACKGROUND
It has been shown that patients with low GCS at admission,
unresponsive pupils, bihemispheric transventricular injury, and
subarachnoid hemorrhage usually have a poor outcome after
cerebral gunshot wounds (1). This penetrating brain injury was
treated as a severe traumatic brain injury (TBI) (GCS3–8). At
our department, patients suffering from severe TBI are mechan-
ically ventilated, and sedated with morphine, midazolam, and/or
propofol. If mass lesions are present, they are evacuated as deemed
appropriate. Mean arterial pressure (MAP) is measured intra-
arterially. Cerebral perfusion pressure (CPP) is calculated as MAP–
ICP with the transducers placed at mid-lateral ventricular level.
The patients are treated in 30° sitting position. ICP is tar-
geted at <20 mmHg (2) and CPP is targeted at 50–70 mmHg.
Targets are achieved with intravenous infusions, vasopressors,
osmotic therapy, and intermittent CSF drainage from ventricu-
lar catheters, ventilation, temperature control, and decompres-
sive craniotomy, if needed. Patients are normoventilated (pCO2
approx. 4.5 kPa). Blood glucose is targeted at 4–8 mmol/L and
hemoglobin is targeted at >90 g/L. Temperature is regulated at
37°C with paracetamol or external wrapping cooling systems.
If ICP could not be regulated with the previously described
techniques, sodium thiopental is infused, limited by burst sup-
pression and monitored with continuous electroencephalography
(EEG). Mild hypothermia (35–36°C) is used for high refractory
ICP.
Intracerebral microdialysis is performed routinely in patients
suffering from severe traumatic brain injuries (3). Increasing LPR
>40 indicates tissue ischemia or mitochondrial dysfunction. We
routinely obtain serum samples of the biomarker S100B every
12 h and recognize secondary peaks as a negative prognostic
indicator (4). Hyperbaric treatment seemed already in the mid-
1970s to improve outcome in patients suffering from TBI pre-
senting mid-brain symptoms (5), especially during 1.5–2.0 bar for
40 min (6). Recent studies by Rockswold and co-workers have
shown beneficial effect by using hyperbaric treatment with sig-
nificantly improved markers of oxidative metabolism, reduced
intracranial hypertension, and improvement in markers of cere-
bral toxicity as well as a significant reduction in mortality and
improved favorable outcome (7, 8).
In the present case report, we present a patient with rela-
tively high GCS and normal pupil response at admission, despite
a gunshot wound with a detrimental bihemispheric trajectory.
The patient developed an increasing LPR, indicating local tissue
damage due to ischemia or mitochondrial dysfunction, and was
thus treated with 2.8 bar HBO. The intracranial conditions of the
patient improved, and the patient survived despite unfavorable
odds.
The current setting presents a higher pressure than reported
by the Rockswold group (8). This regimen was chosen as a res-
cue measure of “last resort,” facing the uncontrolled increase in
LPR, because of presumed cerebral mitochondrial dysfunction. An
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FIGURE 5 | Illustrating how the brain tissue oxygen pressure (PBtO2, black), the arterial blood gas oxygen pressure (pO2, red), and fraction of inspired
oxygen (FIO2, blue) changed over time. The red arrows indicate timing for HBO treatments. All the measurements presented are performed at normobaric
conditions (before and after HBO).
FIGURE 6 | MRI performed [susceptibility weighted imaging protocol
(SWI)] on day 16 after injury reveals bilateral temporal damage and
hemorrhage along the bullet, yet no signs of ischemic injury.
increased FIO2 was tested, but failed to improve cerebral metabolic
conditions (Figure 5). The patient’s vital and metabolic parame-
ters were thoroughly monitored during the HBO procedure, and
the pressure would be lowered if any adverse effects had been
detected. Despite the success achieved in this particular case, we
do not recommend this regimen as a standard HBO procedure
in severe TBI cases. More studies are necessary to determine the
optimal dose regimen and to individualize the treatment.
The graphs presented are exported using the LabPilot® software
(Microdialysis AB, Stockholm, Sweden).
DISCUSSION
Pathophysiology following TBI is complex, initiated by the
primary damage to the brain parenchyma and a subsequent disin-
tegration of the blood–brain barrier (BBB), leading to the devel-
opment of cerebral edema. An early decrease in cerebral blood
flow, hampering oxygen and substrate delivery to the cerebral tis-
sue, leads to a subsequent development of ischemia, and eventually
cellular death.
The ischemic environment present in the affected tissue, leads
to an impaired mitochondrial function with ensuing anaero-
bic metabolism with increased intracerebral levels of lactate and
increased LPR and an increased risk of development of secondary
brain injuries (9, 10). However, a favorable environment in the
border zone between dead and survivable tissue, may facilitate the
recovery of the affected brain parenchyma, prevent negative effects
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of secondary insults, and by that improve patient outcome (11, 12).
There are several animal models, and clinical TBI studies, elabo-
rating the effects of normobaric hyperoxia (NBO) and HBO in
TBI. Both NBO and HBO are capable of improving physiological
variables, such as cerebral oxygenation (PBtO2) and metabolism
(LPR) (13, 14). Experimental HBO treatments have been shown
to improve mitochondrial function, increase ATP production, and
reduce cell death in the hippocampus (15, 16). Recently, clinical
data provided by professor Rockswold’s group confirmed bene-
ficial effects of HBO in human severe TBI, assessed from both
surrogate endpoints, such as ICP, LPR, PBtO2, but also from a
significant mortality reduction and an increase of favorable out-
come (8). In our case, similar to the study by Rockswold et al., the
intraparenchymal LPR decreased, the PBtO2 increased, and the
ICP decreased after HBO (8). Also, the HBO treatment correlated
to a decrease of serum S100B levels, where secondary increases
often correlate to the development of ischemic injuries, as seen in
a previous study by our group (4). Despite a secondary CT-scan
revealing tissue at risk for further ischemic deterioration, as well as
quickly deteriorating metabolic conditions, no further ischemic,
or other, injury was visible on the MRI performed on day 16.
It is important to note that the clinical course for each patient
is highly individual. Even if the current HBO treatment improved
conditions, its direct effect on outcome is not possible to evaluate
from this particular case. The aim with multi-modal monitoring
is to assess the effects of the individualized therapies provided
for each patient. In this case, HBO treatment was followed by
improved brain oxygenation and a better metabolic status (LPR),
indicating a clinical usefulness.
The hyperbaric facility at Karolinska is equipped with a large
multiplace chamber (HAUX, Germany). The working area of the
chamber is 50m2, and the HBO department is located adjacent to
the ICU. The chamber is equipped with modern ICU-hardware,
similar to the ordinary ICU, but approved for use during hyper-
baric conditions. This makes it possible to provide HBO treatment
to patients in circulatory and respiratory distress, such as toxic
shock syndrome in case of necrotizing soft tissue infections. How-
ever, patients with TBI are not routinely treated in the hyperbaric
chamber at our department. In special cases, HBO treatment could
be considered. Future prospective studies should be launched to
further validate the effect on outcome of HBO treatment in TBI.
CONCLUSION
In this case study, 2.8 bar HBO therapy improved the intracra-
nial biochemical conditions of a patient suffering from a cerebral
bihemispheric gunshot wound, indicating a potential benefit of
HBO treatment. Further studies are warranted to better select
which TBI patients that would best benefit from HBO treatment.
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